NR3C2在胶质瘤中的预后价值及免疫浸润的分析OA
Prognostic value of NR3C2 and immune infiltration analysis in glioma
目的 探讨NR3C2 在胶质瘤中的预后价值及其与免疫浸润程度的相关性.方法 基于癌症基因组图谱(TCGA)数据库胶质瘤患者 RNA-seq 表达数据,分析 NR3C2 的表达特征.采用 Kruskal-Wallis 秩和检验分析 NR3C2 表达与胶质瘤临床病理特征(年龄、异柠檬酸脱氢酶(IDH)状态、1p/19q 联合缺失及 WHO分级)之间的关系.通过 RT-qPCR、Western Blot 和免疫荧光实验验证胶质瘤细胞中 NR3C2 的表达水平.采用 Kaplan-Meier 生存曲线分析 NR3C2 表达与患者总生存期(OS)的关系,并通过受试者工作特征(ROC)曲线评估其预后预测能力.基于单样本基因集富集分析(ssGSEA)算法评估免疫细胞浸润水平,并采用 Spearman相关检验分析 NR3C2 表达与免疫细胞浸润程度之间的相关性.结果 NR3C2 在胶质瘤组织中呈低表达状态,其表达水平与 WHO 分级、IDH 状态、年龄及1p/19q 联合缺失显著相关,且 NR3C2 低表达患者预后较差、生存时间较短.实验结果进一步证实,胶质瘤细胞中 NR3C2 的表达水平低于正常星形胶质细胞.免疫浸润分析显示,NR3C2 低表达与中性粒细胞、T 细胞及巨噬细胞浸润程度的相关性具有统计学意义(P<0.05).结论 NR3C2 在胶质瘤中呈低表达,其表达水平与患者预后及免疫细胞浸润密切相关,提示 NR3C2 可能参与胶质瘤免疫微环境调控,并在肿瘤免疫调节过程中发挥潜在作用.
Objective To explore the prognostic value of NR3C2 in glioma and its relationship with the immune infiltration landscape.Methods Based on RNA-seq expression data from glioma patients in The Cancer Genome Atlas(TCGA)database,the expression characteristics of NR3C2 were systematically analyzed.The Kruskal-Wallis rank-sum test was used to assess the associations between NR3C2 expression and clinicopathological features of glioma,including age,isocitrate dehydrogenase(IDH)status,1p/19q codeletion,and World Health Organization(WHO)grade.The expression levels of NR3C2 in glioma cells were validated by reverse transcription quantitative PCR(RT-qPCR),Western blotting,and immunofluorescence assays.Kaplan-Meier survival analysis was performed to evaluate the association between NR3C2 expression and overall survival(OS),while receiver operating characteristic(ROC)curve analysis was used to assess its predictive performance.Immune cell infiltration levels were estimated using the single-sample gene set enrichment analysis(ssGSEA)algorithm,and Spearman's rank correlation analysis was performed to examine the relationship between NR3C2 expression and immune cell infiltration.Results NR3C2 expression was significantly down-regulated in glioma tissues and showed significant associations with WHO grade,IDH status,age,and 1p/19q codeletion.Lower NR3C2 expression was associated with poor prognosis and reduced survival duration.Experimental assays further demonstrated that NR3C2 expression in glioma cells was significantly decreased compared with that in normal astrocytes.Immune infiltration analysis indicated significant correlations between low NR3C2 expression and the infiltration of neutrophils,T cells,and macrophages.Conclusions NR3C2 is expressed at low levels in glioma,and its expression is closely associated with patient prognosis and immune cell infiltration,suggesting that NR3C2 may be involved in the regulation of the glioma immune microenvironment and play a potential role in tumor immune modulation.
李沛隆;任燕红;沈志远;王常州;吴金霞;王秀存
221002 徐州,徐州医科大学附属医院神经外科221002 徐州,徐州医科大学附属医院神经外科221002 徐州,徐州医科大学附属医院神经外科221002 徐州,徐州医科大学附属医院神经外科徐州医科大学生理学教研室221002 徐州,徐州医科大学附属医院神经外科
医药卫生
胶质瘤NR3C2低表达预后免疫细胞浸润
gliomaNR3C2low expressionprognosisimmune infiltration
《临床神经外科杂志》 2026 (2)
158-164,7
徐州市重点研发计划项目(KC22242)
评论